Cytodyn, Inc.
Clinical trials sponsored by Cytodyn, Inc., explained in plain language.
-
Last-Resort drug access opens for aggressive breast cancer patients
Disease control AVAILABLEThis program offers investigational leronlimab to adults with advanced triple-negative breast cancer who have run out of standard treatments. Participants must have stage IIIB-IV disease and cannot join a clinical trial. The goal is to provide a potential treatment option when no…
Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 26, 2026 07:40 UTC
-
New combo aims to shrink Hard-to-Treat colon tumors
Disease control Recruiting nowThis study tests whether adding the experimental drug leronlimab to standard chemotherapy can shrink tumors in people with a common type of advanced colorectal cancer that has stopped responding to prior treatments. About 60 adults with microsatellite stable (MSS) metastatic colo…
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC